June 27, 2025

Empagliflozin has kidney protective effects in acute myocardial infarction

June 27, 2025 / Research update / InnovateMed Author / acute myocardial infarction

by Elana Gotkine edited by Gaby Clark, reviewed by Andrew Zinin Empagliflozin has kidney protective effects and reduces heart failure outcomes across baseline kidney function among patients with acute myocardial infarction (MI), according to a study published online June 13 in Nature Cardiovascular Research. Rahul Aggarwal, M.D., from Harvard Medical School in Boston, and colleagues examined the cardiovascular-kidney effects […]

Empagliflozin has kidney protective effects in acute myocardial infarction Read More »

Diabetes drug may serve as alternative treatment option for hydrocephalus

June 27, 2025 / Research update / InnovateMed Author / hydrocephalus

by Melissa Rohman, Northwestern University edited by Stephanie Baum, reviewed by Andrew Zinin Credit: Unsplash/CC0 Public Domain A drug commonly used to treat type 2 diabetes may reduce excess fluid in the brains of patients with hydrocephalus, which could help treat the disease less invasively than current treatments, according to a Northwestern Medicine study published in the Journal of Clinical Investigation.

Diabetes drug may serve as alternative treatment option for hydrocephalus Read More »

Turning off the enzyme behind high cholesterol may pave path for new therapies for multiple inflammatory diseases

June 27, 2025 / Research update / InnovateMed Author / inflammatory disease

by Katherine Egan Bennett, University of Texas at Arlington edited by Stephanie Baum, reviewed by Andrew Zinin Credit: Langmuir (2025). DOI: 10.1021/acs.langmuir.4c03005 Scientists at The University of Texas at Arlington have identified a new enzyme that can be “turned off” to help the body maintain healthy cholesterol levels—a significant development that could lead to new treatments for diseases that affect

Turning off the enzyme behind high cholesterol may pave path for new therapies for multiple inflammatory diseases Read More »

How a drug used to treat Parkinson’s disease might affect the brain

June 27, 2025 / Research update / InnovateMed Author / parkinson

by Simon Fraser University edited by Stephanie Baum, reviewed by Andrew Zinin Rhythmic beta-frequency responses to dopamine replacement therapy (DRT). (A) Brain maps on the left and right indicate the mean and standard deviation, respectively, of region-wise rhythmic beta-frequency neurophysiological responses to DRT. (B) From left to right, brain maps indicate the normative spatial patterns of D1 and

How a drug used to treat Parkinson’s disease might affect the brain Read More »

New study may pave the way for targeted cancer treatments

June 27, 2025 / Research update / InnovateMed Author / cancer treatment

by Touro University edited by Stephanie Baum, reviewed by Andrew Zinin Structural proteomics reveals isoform differences upon progesterone response element (PRE) binding. Credit: Nature Communications (2025). DOI: 10.1038/s41467-025-59458-y Imagine a drug that halts cancer without side effects or risks. That future may be a bit nearer thanks to recent research led by Raj Kumar, Ph.D., chair of the Department

New study may pave the way for targeted cancer treatments Read More »

Generic cancer drugs are failing quality tests

June 27, 2025 / News update / InnovateMed Author / cancer drugs

Cancer patients in more than 100 countries are at risk of receiving ineffective treatments and potentially fatal side effects, reports a team from the Bureau of Investigative Journalism (TBIJ). Generic drugs are used all around the world, but they’re especially relied upon in places with fewer resources and less access to more expensive treatments.

Generic cancer drugs are failing quality tests Read More »

Epigenetic enzyme SETD1B drives aggressive growth in acute myeloid leukemia

June 27, 2025 / Research update / InnovateMed Author / leukemia

Download PDF Copy Reviewed Chiba UniversityJun 26 2025 Acute myeloid leukemia (AML) is an aggressive cancer affecting the blood and bone marrow that progresses rapidly, making immediate treatment essential. While chemotherapy and targeted drugs have improved outcomes for some patients, many forms of AML remain resistant to treatment, and relapses are common. A new study sheds

Epigenetic enzyme SETD1B drives aggressive growth in acute myeloid leukemia Read More »

Saliva analysis could reveal the risk of developing cancer, heart disease or Parkinson’s

June 27, 2025 / Research update / InnovateMed Author / parkinson

The study led by a team at the EHU has identified hundreds of molecular markers in the oral cavity that can reflect pathological processes in other parts of the body Peer-Reviewed Publication University of the Basque Country FacebookXLinkedInWeChatBlueskyMessageWhatsAppEmail image: Jose Ramon Bilbao Catala and Alba Hernangomez Laderas, main authors of the research. view more Credit: Photo:

Saliva analysis could reveal the risk of developing cancer, heart disease or Parkinson’s Read More »